In The Media
In The News
Drk Kari Nadeau interviewed with Hedgeye TV Presentation on COVID19 Vaccines.
During the current COVID-19 pandemic, Dr. Kari Nadeau led one of the key successful NIH NIAID-funded Remdesivir clinical trials as a potential therapeutic for SARS-CoV-2. On April 29th, Dr. Anthony Fauci, the Director of NIH and a current member of the US Coronavirus Task Force, announced that Remdesivir will become the “new standard of care” for COVID-19.
Grand Rounds, Feat. Dr. Kari Nadeau: 6/03/20 Coronavirus (COVID 19) Grand Rounds - Stanford Department of Medicine
Topic: The Science and Status of COVID Vaccines Karla Kirkegaard PhD
Violetta L. Horton Professor of Genetics and former Chair of the Department of Microbiology and Immunology
Scott Boyd, MD PhD - Associate Professor of Pathology and Endowed Faculty Scholar in Allergy and Immunology
Bali Pulendran PhD - Violetta L. Horton Professor and Professor of Microbiology and Immunology
Kari Nadeau, MD, PhD - Naddisy Foundation Endowed Professor of Medicine and Pediatrics and Director of the Sean N. Parker Center for Allergy and Asthma Research; Senior Director of Clinical Research for Division of Hospital Medicine.
Exclusive Interview with Kari C. Nadeau, an American Physician-Scientist Focused on Dr. Kari Nadeau | Allergies and Asthma in the COVID-19 Age
Our Health Talks featured allergy and asthma expert Dr. Kari Nadeau to discuss the management and implications of those very conditions in the COVID-19 age. This conversation challenges many of the assumptions we have about what these concerns mean for COVID-19 risk profile and outcomes.
Our Exclusive Interview with Kari C. Nadeau, an American Physician-Scientist Focused on Allergy & Asthma Treatment at Stanford University School of Medicine.
"We always think about improving patients’ lives through innovative research and compassionate care. We hope to use precision medicine to help patients effectively." Kari says.
Some treatments can train the immune system to react less to proteins that normally send it into overdrive
Jenny Edwards didn’t want to go back home to Canberra, the Australian capital. She added seven days to a five-day family vacation “specifically to stay out of the smoke.” But it didn’t matter.
Immunotherapy could provide long-term protection against severe allergic reactions to peanuts, a new study suggests.
Monster fires in California have killed at least three people so far and burned tens of thousands of acres over the last couple of weeks. At least five fires are burning in the state; the Kincade Fire — which began two weeks ago — is still just 88 percent contained. The blazes have closed schools and businesses, forced hundreds of thousands of people to evacuate, and left behind charred rubble where entire communities once stood.
As fires rage in the Bay Area, scientists launch study to track long-term effects of smoke on the heart, lungs and immune system.
There is concern by Stanford scientists that inhaling wildland fire smoke could weaken the immune systems of children. They've embarked on a major study, but need the public's help as smoke spreads over the Bay Area. Here's how you could help with this important research.
A World Without Food Allergy: Professor Kari Nadeau Presents for the UNIKA-T Speaker Series on Behalf of the Center for Interdisciplinary Health Research (ZIG, University of Augsburg)
Professor Kari Nadeau, Director at the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, California, presented her topic “A word without food allergy - fiction or reality” within the scope of the UNIKA-T Speaker Series.
Stanford professor Kari Nadeau lives the life, some would say the dream, of what Judah Folkman has called the inquisitive physician, integrating her deep knowledge of chemistry, her experience in biotech drug development, and her clinical acumen and deeply-felt compassion for patients to bring the best of medicine and science to children and adults with food allergies.
The Future of Everything with Russ Altman:
Sharon Chinthrajah, a clinical associate professor at the Stanford School of Medicine, explains ways to protect your health from air pollution while decreasing energy consumption.
- An expert advisory panel says a new treatment option for peanut allergies should be approved.
- The medication is called Palforzia and it would be the first drug to target these types of dangerous allergies.
- It is not considered a full cure but a way to reduce dangerous symptoms.
This is example text for the text & image NIH and Partners to Assess Whether Omalizumab Can Reduce Allergic Reactions
Already this summer, the Bay Area has had heat waves topping 100 degrees. Most Americans in the rest of the country are facing extreme heat this week. These dangerous events are becoming more common and are putting clean air, public health and lives at risk. They’re just the latest indicator that we are facing a climate health emergency.
San Francisco Chronicles - July 23, 2019
What’s the difference between charitable giving from ordinary people and philanthropic giving from the very wealthy?
The New York Times - November 16, 2018
The Doctors TV - September 20, 2018
Study Finds Combining Xolair with OIT Led to Quicker, Safer Desensitization with Multiple Food Allergens
Allergic Living - December 12, 2017
It’s been a harrowing journey for 10-year-old Tessa Grosso and her family. Tessa has multiple food allergies, and her severe reactions to even the slightest trace of certain substances could have killed her.